| 24125888
|
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. |
Bioorg Med Chem Lett |
2013 |
Prior AM;Kim Y;Weerasekara S;Moroze M;Alliston KR;Uy RA;Groutas WC;Chang KO;Hua DH |
View
More |
| 27981189
|
Untangling the Gordian knot of HIV, stress, and cognitive impairment. |
Neurobiol Stress |
2016 |
Valdez AN;Rubin LH;Neigh GN |
View
More |
| 28778471
|
Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2017 |
Zhang Q;Cao R;Liu A;Lei S;Li Y;Yang J;Li S;Xiao J |
View
More |
| 29530860
|
Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro. |
Antimicrob Agents Chemother |
2018 |
Kitano M;Hosmillo M;Emmott E;Lu J;Goodfellow I |
View
More |
| 29866517
|
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro. |
Bioorg Med Chem Lett |
2018 |
Jung E;Lee JY;Kim HJ;Ryu CK;Lee KI;Kim M;Lee CK;Go YY |
View
More |
| 30646829
|
Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. |
J Biomol Struct Dyn |
2020 |
Jain S;Amin SA;Adhikari N;Jha T;Gayen S |
View
More |
| 33515606
|
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development. |
Antiviral Res |
2021 |
Liu C;Boland S;Scholle MD;Bardiot D;Marchand A;Chaltin P;Blatt LM;Beigelman L;Symons JA;Raboisson P;Gurard-Levin ZA;Vandyck K;Deval J |
View
More |
| 35278580
|
Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors. |
Antiviral Res |
2022 |
Scholle MD;O'Kane PT;Dib S;Gurard-Levin ZA |
View
More |
| 35625804
|
Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease. |
Biomedicines |
2022 |
Gambacorta N;Caputo L;Quintieri L;Monaci L;Ciriaco F;Nicolotti O |
View
More |
